South African health experts are calling on governments to use legally available mechanisms to promote the production or import of generic drugs in their countries. Pharmaceutical patents continue to drive up drug prices, making it expensive to treat patients. This often leads to limited access to health care, especially in developing countries where the disease burden is high, but public health budgets remain low, experts said.